The Evolution of Acquired Resistance to BRAFV600E kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular Remodeling.
Xu G, Luo Y, Wu W, Liu X, Yu X, Bao Y, He X, Yu J, Li Y, Yang J, Zhang R, Yu C, Chen H, Xu J, Hu J, Jing J, Shi H.
Xu G, et al. Among authors: wu w.
J Invest Dermatol. 2022 Feb;142(2):445-458. doi: 10.1016/j.jid.2021.07.162. Epub 2021 Aug 4.
J Invest Dermatol. 2022.
PMID: 34358527
Free article.